In the BioHarmony Drug Report Database

"Preview" Icon

Darifenacin hydrobromide

Enablex, Emselex (darifenacin hydrobromide) is a small molecule pharmaceutical. Darifenacin hydrobromide was first approved as Enablex on 2004-10-22. It is used to treat overactive urinary bladder and urge urinary incontinence in the USA. It has been approved in Europe to treat overactive urinary bladder and urge urinary incontinence. It is known to target muscarinic acetylcholine receptor M1 and muscarinic acetylcholine receptor M3.

 

Trade Name

 

Emselex
 

Common Name

 

darifenacin hydrobromide
 

ChEMBL ID

 

CHEMBL1200935
 

Indication

 

overactive urinary bladder, urge urinary incontinence
 

Drug Class

 

Muscarinic receptor antagonists

Image (chem structure or protein)

Darifenacin hydrobromide structure rendering